J44.81
Bronchiolitis obliterans and bronchiolitis obliterans syndrome
Clinical Classification Guidelines
Inclusion Terms
- Obliterative bronchiolitis
Code First
- , if applicable:
- complication of bone marrow transplant (T86.09)
- complication of stem cell transplant (T86.5)
- heart-lung transplant rejection (T86.31)
- lung transplant rejection (T86.810)
- other complications of heart-lung transplant (T86.39)
- other complications of lung transplant (T86.818)
Code Also
- , if applicable, associated conditions, such as:
- chronic graft-versus-host disease (D89.811)
- chronic lung allograft dysfunction (J4A.-)
- chronic respiratory conditions due to chemicals, gases, fumes and vapors (J68.4)
Medical Intelligence & Overview
Bronchiolitis obliterans, also known as obliterative bronchiolitis, is a rare lung condition characterized by inflammation and scarring of the small airways in the lungs. This scarring can lead to narrowing or complete blockage of the airways, resulting in breathing difficulties. Often, it develops gradually and may be related to various underlying causes. Proper understanding of this condition can help manage its symptoms and improve quality of life.
Causes & Symptoms
Clinical Causes: Respiratory infections, especially viral infections Inhalation of harmful substances such as fumes, gases, or chemicals Bone marrow or lung transplants leading to graft-versus-host disease Autoimmune diseases like rheumatoid arthritis Exposure to inhaled toxins, including certain dusts or fumes Previous lung injury or injury from external trauma Certain medications or radiation therapy
Key Symptoms: Shortness of breath, especially during physical activity Chronic cough that doesn't go away Wheezing or a whistling sound when breathing Fatigue or weakness Unexplained weight loss Chest tightness or discomfort Frequent respiratory infections
Diagnostic & Treatment
Diagnosis Path: Diagnosing bronchiolitis obliterans typically involves a combination of medical history, physical examination, and specialized tests. These tests may include pulmonary function tests (PFTs) to assess airflow limitations, imaging studies like chest X-rays or high-resolution CT scans to visualize lung changes, and lung biopsies to confirm scarring and inflammation of the small airways. A comprehensive evaluation helps to distinguish this condition from other respiratory illnesses.
Treatment Protocols: While there is no cure for bronchiolitis obliterans, various treatments aim to manage symptoms and prevent progression. These may include medications such as corticosteroids to reduce inflammation, bronchodilators to open airways, and immunosuppressive drugs for certain cases. Oxygen therapy and pulmonary rehabilitation can improve breathing and overall function. In severe cases, lung transplantation might be considered. Regular medical follow-up is crucial for monitoring disease progression and adjusting treatment plans accordingly.
Clinical Advice & FAQs
Billing Guidance
Is J44.81 a billable ICD-10 code?
Yes, J44.81 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report J44.81?
Clinical documentation must specify the nature of Bronchiolitis obliterans and bronchiolitis obliterans syndrome and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
